Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

262.51
-0.5300-0.20%
Pre-market: 262.34-0.1700-0.06%05:15 EDT
Volume:3.12M
Turnover:818.82M
Market Cap:463.96B
PE:74.16
High:264.00
Open:261.99
Low:260.98
Close:263.04
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.70
T/O Rate:0.18%
Dividend:6.83
Dividend Rate:2.60%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-78.17
PE(LYR):111.23

Loading ...

Integer Holdings Q2 Sales Fall 2.6%; KKR to Buy Company for $5.7 Billion

Reuters
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

U.S. Research Roundup-Abbvie, Amazon, Illumina

Reuters
·
Aug 03

JPMorgan Adjusts Price Target on AbbVie to $285 From $280

MT Newswires Live
·
Aug 01

Abbvie Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), AbbVie (ABBV) and Cencora (COR)

TIPRANKS
·
Aug 01

AbbVie Earnings Beat Forecasts as Skyrizi Sales Soar 24%. Why the Stock is Falling.

Dow Jones
·
Aug 01

Sector Update: Healthcare

MT Newswires Live
·
Aug 01

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

TIPRANKS
·
Aug 01

AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline

TIPRANKS
·
Aug 01

AbbVie Publishes Pipeline Presentation Highlighting July 2026 R&D Program Updates

Reuters
·
Jul 31

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

Benzinga Earnings
·
Jul 31

Movement Alert|AbbVie Falls 3.04% in Regular Trading, Q2 Beat Overshadowed by Full-Year EPS Guidance Cut on Acquisition Dilution

Market Focus
·
Jul 31

AbbVie says ‘quite pleased’ with Skyrizi momentum

TIPRANKS
·
Jul 31

AbbVie Has 2Q Beat Helped by Skyrizi and Rinvoq

Dow Jones
·
Jul 31

Abbvie Shares Down 2.2% After Co Trims 2026 Profit Forecast

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says NOW Expect Total Annual Net Revenue of Approximately $67.6 Billion, Increase of $300 Million Versus Previous Forecast - Conf Call

THOMSON REUTERS
·
Jul 31

Abbvie Exec Says in Third Quarter it Expects Adjusted Profit Per Share Between $3.84 and $3.88 - Conf Call

THOMSON REUTERS
·
Jul 31

AbbVie Bought Apogee to Strengthen Its Portfolio. Now It's Cutting Earnings Guidance.

Dow Jones
·
Jul 31